A

ATP (Apple Tree Partners)

46 employees

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Investor insights

Sectors invested in

Biotechnology34

Health Care27

Therapeutics24

Medical14

Biopharma9

Drug Development9

Pharmaceutical8

Life Science7

Medical Device7

Myelopreservation6

Chemotherapy6

Stapled Peptides6

Chemoprotection6

Supportive Care6

Chemistry6

Biopharmaceuticals6

Genetics6

Oncology5

Clinical Trials4

biotechnology4

Funding rounds participated in

$34M sweet spot round size

Most of their 53 investments are in rounds between $15M and $50M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology

Medical Device

Medtech

Biotech

Finance

Venture capital

Life sciences

Pharmaceutical

Venture Capital

Pharmaceuticals

Date founded

1999

Investments made

I

Initial Therapeutics raised $75M on May 1, 2023

Investors: ATP (Apple Tree Partners)

A

Aethon Therapeutics raised $30M on January 9, 2023

Investors: NYU Medical Center and ATP (Apple Tree Partners)

A

Ascidian Therapeutics raised $50M on October 12, 2022

Investors: ATP (Apple Tree Partners)

G

Galvanize Therapeutics, Inc. raised $100M on September 15, 2022

Investors: Gilmartin Capital LLC, Intuitive Surgical and ATP (Apple Tree Partners)

M

Marengo Therapeutics raised $80M on November 8, 2021

Investors: ATP (Apple Tree Partners)

I

Intergalactic Therapeutics raised $75M on October 7, 2021

Investors: ATP (Apple Tree Partners)

R

Replicate Bioscience, Inc. raised $40M on September 8, 2021

Investors: ATP (Apple Tree Partners)

G

Galaxy Medical raised $10M on March 16, 2021

Investors: ATP (Apple Tree Partners)

R

Replicate Bioscience, Inc. raised $6M on February 16, 2021

Investors: ATP (Apple Tree Partners)

A

Aulos Bioscience raised $40M on January 8, 2021

Investors: ATP (Apple Tree Partners)

FAQ